The Northern Health Science Alliance (NHSA) has partnered with Zicom MedTacc in Singapore in a strategic deal which will see companies come to the North of England when developing and internationalising new medical technology.
A memorandum of understanding (MOU) has been signed between the two organisations which will see Singaporean Medtech companies coming to the region, through the NHSA, for their British clinical validation and economic impact assessments. This relationship will provide the North with access to innovative new technologies and treatments and will help support the growth of the North’s already thriving medtech sector.
The long-term aim is to support high skilled-jobs and investment in the Northern region which has seen health innovation identified nationally as a key economic strength.
Dr Hakim Yadi OBE CEO of the NHSA said: “We have been working with Zicom MedTacc for the last two years, this MoU formalises our existing working relationship and will support us in establishing a more enduring partnership.
“This offers practical commercial opportunities for both MedTech companies and life science researchers in Singapore as well as in the North of England, we hope it encourages collaboration between the two countries which will enable companies from both geographies to expand into their reciprocal international markets.
“This means Northern medtech diagnostic and digital health companies will be able to use our strategic partners in Singapore as a launching pad into the Singaporean and wider Asia Pacific markets, both of which are growing phenomenally quickly.”
The NHSA is an alliance of the top eight universities, NHS teaching Trusts and four Academic Health Science Networks in the North of England covering a 15 million population.
Zicom MedTacc is a part of the Zicom Innovations Group, an Integrated Medtech company with decades of engineering, regionalisation and manufacturing expertise.
NHSA CEO Dr Yadi visited Singapore last month [JANUARY] to meet with executives from Zicom MedTacc including Chief Executive Sim Kok Hwee where the MOU was signed.
Mr Kok Hwee said: “We have forged a close partnership with the NHSA and are confident that through the NHSA, we would be able to help more Singaporean healthcare and medical technology companies which are interested in establishing a presence in the North of England.
“Likewise, we are extremely delighted to be able to provide support to UK companies coming to Singapore to explore opportunities be it research and clinical collaborations or as a launchpad for breaking into the Singapore or other Asian markets. We look forward to more companies in both countries being able to expand their global footprint via such collaborative efforts between the NHSA and Zicom.”
Peter Ellingworth, CEO of the Association for British Healthcare Industries said: “The Government has highlighted the importance of international trade in ensuring the success of Brexit. Support for UK HealthTech companies will enable access to emerging markets and we look forward to working with NHSA on international activities to deliver this.”
For more interviews, comment etc. contact Hannah.Davies@theNHSA.co.uk, 07342882383.
The NHSA ltd is a partnership established by the leading Universities and NHS Hospital Trusts in the North of England to improve the health and wealth of the region by creating an internationally recognised life science and healthcare system. It links eight universities and eight research-intensive NHS Teaching Trusts with four Academic Health Science Networks (AHSNs covering a population of over 15 million.
The NHSA’s members include: Newcastle University, Durham University, University of York, University of Liverpool, University of Manchester, Lancaster University, University of Sheffield, University of Leeds, The Newcastle Upon Tyne Hospitals NHS Trust, South Tees Hospitals NHS Trust, Leeds Teaching Hospitals, Sheffield Teaching Hospitals, Manchester University NHS Foundation Trust, The Royal Liverpool and Broadgreen University Hospitals, Hull and East Yorkshire Hospitals, Lancashire Teaching Hospitals, Innovation Agency AHSN, Yorkshire and Humber AHSN, North East North Cumbria AHSN, Greater Manchester AHSN.
For more information on the NHSA visit www.theNHSA.co.uk
Related News Articles
NHSA appoints Dr Mandy Dixon to lead its corporate engagement strategy
NHSA welcomes health and life sciences expert, Dr Mandy Dixon, to the team
£4.5 million collaboration to back health innovations for patients
£4.5m collaboration between the NHSA and MedCity will foster economic growth and help speed up the development of health innovations to the public.
NHSA visit to Asia sparks collaboration interest in North of England
Innovation and research collaboration links between Asia and the North have been strengthened following the NHSA’s recent visit to Japan and South Korea.